Physical Activity Interferes with the Immunomodulatory Effect of the Antineoplastic Drug NSC631570

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|16|1|49-59

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.16, Iss.1, 2015-01, pp. : 49-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Immunomodulatory Effects of Physical Activity

By  

Current Pharmaceutical Design, Vol. 22, Iss. 24, 2016-07 ,pp. : 3730-3748

Bentham Science Publishers

Access to resources Recommend Favorite

Mutagenic and antimitotic activity of the immunomodulatory drug tubosan

By Kibrik B.   Prokhorova I.   Pesnya D.  

Pharmaceutical Chemistry Journal, Vol. 47, Iss. 5, 2013-08 ,pp. : 261-263

Springer Publishing Company

Access to resources Recommend Favorite

The effects of high physical activity on pharmacokinetic drug interactions

By Lenz Thomas L  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 3, 2011-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

Exisulind, a selective apoptotic antineoplastic drug

By Goluboff Erik T  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 10, 2001-10 ,pp. : 1875-1882

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxic-antineoplastic activity of hydroquinone derivatives

By Molinari A.   Oliva A.   Reinoso P.   del Corral J.M.M.   Castro M.A.   Gordaliza M.   Gupta M.P.   Sols P.   San Feliciano A.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 2, 2002-02 ,pp. : 177-182

Elsevier

Access to resources Recommend Favorite